Online

Placing Regulatory Strategy at the Core of MedTech Innovation

Online Oregon

Placing Regulatory Strategy at the Core of MedTech InnovationDevice and Diagnostic Regulatory Webinar, presented by OCTRI and IMed Consulting Recognizing the importance of early engagement in regulatory thinking is key to shaping your commercial strategy. This webinar will provide valuable insights into strategically navigating clinical risks and providing compelling evidence for the safety and efficacy of […]

OHSU Innovates Seminar Series: “Securing Non-Dilutive Funding for Innovative Businesses”

Online Oregon

OHSU Innovates Seminar Series: “Securing Non-Dilutive Funding for Innovative Businesses”By Nyah Zarate, PhD ChEngDr. Nyah Zarate, PhD, serves as the principal investigator and founder of Continuous Solutions Inc, established in 2014 in Portland, OR. With over 15 years of experience in engineering research and development, Dr. Zarate has adeptly cultivated a research team and laboratory, resulting […]

NIH Webinar: Nestorone®/Testosterone Male Contraceptive Gel

Online Oregon

Attend an NIH free NIH webinar. Attendees will learn about a first-of-its-kind male contraceptive hormonal gel, Nestorone®/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical, daily self-applied transdermal gel is designed to provide full sperm suppression within 8-12 weeks and be reversible after 12-16 weeks of […]

NCI Technology Opportunity Webinar: Automated Acoustophoresis Device to Radio-Label & Isolate Cells for Immunotherapy Treatment

Online Oregon

Host Joseph Conrad Agenda Register to attend a free NIH webinar. Attendees will learn about the research behind a proposed new automated bench-top device for labeling immunotherapy cells with 89Zr-oxine for Positron Emission Tomography (PET) tracking during treatment. The current method for labeling cells with 89Zr-oxine involves a tedious manual process requiring several rounds of […]

NIH Webinar: Anti-EGFR Antibodies for the Treatment of Human Cancers

Online Oregon

Webinar Overview The presentation will follow a logical sequence of how anti-EGFR antibodies are generated and modified to make them cytotoxic for tumor cells with high levels of EGFR or the variant EGFRvIII. It will specifically focus on beginning with a key mouse monoclonal antibody termed ‘40H3’ and then the transition to the humanization of […]